KRYSTAL BIOTECH INC.
841.1
USD
(+1.08%)
03/14/2025 - 16:34
Closed 15 min delayed data - NASDAQ Stocks
| Open: | 836.8 |
| Change: | +9.0 |
| Volume: | 163 |
| Low: | 832.0 |
| High: | 850.0 |
| High / Low range: | 18.0 |
| Type: | Stocks |
| Ticker: | KRYS |
| ISIN: |
KRYSTAL BIOTECH INC. news, videos and press releases - Page 5
For more news please use our advanced search feature.
KRYSTAL BIOTECH INC. - More news...
KRYSTAL BIOTECH INC. - More news...
- 05/18/2020 - 20:15 Krystal Biotech Announces Proposed Public Offering of Common Stock
- 05/14/2020 - 12:00 Krystal Biotech Announces Positive Interim Results from Phase 1/2 Clinical Trial of KB105 in Patients with TGM1-related Autosomal Recessive Congenital Ichthyosis (ARCI)
- 05/04/2020 - 12:00 Krystal Biotech Reports First Quarter 2020 Financial Results and Provides Update on Operational Progress
- 03/10/2020 - 12:00 Krystal Biotech Reports 2019 Financial Results and Business Progress
- 02/25/2020 - 13:00 Krystal Biotech Announces Change in Financial Leadership
- 02/21/2020 - 13:00 Krystal Biotech to Present at the Cowen 40th Annual Healthcare Conference
- 01/24/2020 - 13:00 Krystal Biotech Breaks Ground On Second Commercial Gene Therapy Manufacturing Facility
- 01/21/2020 - 13:00 Krystal Biotech Appoints Jennifer Chien as Chief Commercial Officer
- 11/26/2019 - 13:00 Krystal Biotech to Present at the Piper Jaffray 31st Annual Healthcare Conference
- 11/04/2019 - 13:00 Krystal Biotech Reports Third Quarter 2019 Financial and Operating Results
- 10/29/2019 - 12:00 Krystal Biotech Announces Final Update from Phase 1/2 Clinical Trial of KB103 ("bercolagene telserpavec," "B-VEC")
- 10/10/2019 - 12:00 Krystal Biotech Receives Positive EMA Opinion on Orphan Designation for KB105 to Treat Patients With TGM1 Deficient Autosomal Recessive Congenital Ichthyosis
- 09/30/2019 - 12:00 Krystal Biotech to Present at the Cantor 2019 Global Healthcare Conference and Chardan's 3rd Annual Genetic Medicines Conference
- 09/27/2019 - 12:00 Krystal Biotech Announces Granting of its First Foreign Patent and Reinforces its IP Portfolio with a New U.S. Patent
- 09/04/2019 - 12:00 Krystal Biotech Announces Initiation of Phase 1/2 Study of KB105 in Transglutaminase-1 (“TGM1”) Deficient Autosomal Recessive Congenital Ichthyosis (“ARCI”)
- 08/27/2019 - 20:05 Krystal Biotech Announces Attendance at Citi’s 14th Annual Biotech Conference
- 08/05/2019 - 12:00 Krystal Biotech Reports Second Quarter 2019 Financial and Operating Results
- 07/01/2019 - 13:05 Krystal Biotech, Inc. Added to the Russell 2000 Index
- 06/24/2019 - 23:49 Krystal Biotech Announces Pricing of $100.0 Million Public Offering of Common Stock
- 06/24/2019 - 20:47 Krystal Biotech Announces Proposed $100 Million Public Offering of Common Stock
- 06/24/2019 - 12:00 Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial (“GEM-2 study”) of KB103 and Receives Regenerative Medicine Advanced Therapy (“RMAT”) Designation from FDA for KB103
- 06/14/2019 - 12:00 Krystal Submits Investigational New Drug (IND) Application for KB105, Topical Gene Therapy Candidate for Transglutaminase-1 Deficient Autosomal Recessive Congenital Ichthyosis
- 05/15/2019 - 12:00 Krystal Biotech to Present at the RBC Capital Markets 2019 Healthcare Conference
- 05/06/2019 - 12:00 Krystal Biotech Reports First Quarter 2019 Financial Results and Provides Corporate Update
- 04/29/2019 - 12:00 Krystal Biotech Announces Five Presentations of Clinical and Preclinical Data at the Society for Investigative Dermatology Annual Meeting
- 03/29/2019 - 12:00 EMA Grants PRIME Eligibility for KB103 to Treat Dystrophic Epidermolysis Bullosa
- 03/12/2019 - 12:00 Krystal Biotech Reports 2018 Financial Results and Business Progress
- 03/06/2019 - 13:00 Krystal Biotech Continues Vertical Integration with Official Inauguration of Ancoris Gene Therapy Manufacturing Facility at its Pittsburgh Headquarters
- 03/04/2019 - 13:00 Krystal Strengthens Board of Directors with Appointment of Julian S. Gangolli
- 03/01/2019 - 13:00 Krystal Biotech to Present at the Cowen and Company 39th Annual Health Care Conference
